4.7 Article

Role for PPARγ in obesity-induced hepatic steatosis as determined by hepatocyte- and macrophage-specific conditional knockouts

期刊

FASEB JOURNAL
卷 25, 期 8, 页码 2538-2550

出版社

FEDERATION AMER SOC EXP BIOL
DOI: 10.1096/fj.10-173716

关键词

nuclear receptors; liver cells; nonalcoholic fatty liver disease

资金

  1. Ministerio de Ciencia e Innovacion (MICINN) [SAF 09/08767, AP2007-02004]
  2. Instituto de Salud Carlos III
  3. IDIBAPS

向作者/读者索取更多资源

Peroxisome proliferator-activated receptor (PPAR) gamma is a nuclear receptor central to glucose and lipid homeostasis. PPAR gamma role in nonalcoholic fatty liver disease is controversial because PPAR gamma overexpression is a general property of steatotic livers, but its activation by thiazolidinediones reduces hepatic steatosis. Here, we investigated hepatic PPAR gamma function by using Cre-loxP technology to generate hepatocyte (PPAR gamma(Delta hep))- and macrophage (PPAR gamma(Delta mac))-specific PPAR gamma-knockout mice. Targeted deletion of PPAR gamma in hepatocytes, and to a lesser extent in macrophages, protected mice against high-fat diet-induced hepatic steatosis. Down-regulated expression of genes involved in lipogenesis (SCD1, SREBP-1c, and ACC), lipid transport (CD36/FAT, L-FABP, and MTP), and beta-oxidation (PPAR alpha and ACO) was observed in PPAR gamma(Delta hep) mice. Moreover, PPAR gamma(Delta hep) mice showed improved glucose tolerance and reduced PEPCK expression without changes in Pcx, Fbp1, and G6Pc expression and CREB and JNK phosphorylation. In precision-cut liver slices (PCLSs) and hepatocytes, rosiglitazone either alone or in combination with oleic acid increased triglyceride accumulation, an effect that was blocked by the PPAR gamma antagonist biphenol A diglycidyl ether (BADGE). PCLSs and hepatocytes from PPAR gamma(Delta hep) mice showed blunted responses to rosiglitazone and oleic acid, whereas the response to these compounds remained intact in PCLSs from PPAR gamma(Delta mac) mice. Collectively, these findings establish PPAR gamma expression in hepatocytes as a prosteatotic factor in fatty liver disease.-Moran-Salvador, E., Lopez-Parra, M., Garcia-Alonso, V., Titos, E., Martinez-Clemente, M., Gonzalez-Periz, A., Lopez-Vicario, C., Barak, Y., Arroyo, V., Claria, J. Role for PPAR gamma in obesity-induced hepatic steatosis as determined by hepatocyte-and macrophage-specific conditional knockouts. FASEB J. 25, 2538-2550 (2011). www.fasebj.org

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据